Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mira Woitok"'
Autor:
Mira Woitok, Elena Grieger, Olusiji A Akinrinmade, Susanne Bethke, Anh Tuan Pham, Christoph Stein, Rolf Fendel, Rainer Fischer, Stefan Barth, Judith Niesen
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243286 (2020)
In vitro and ex vivo development of novel therapeutic agents requires reliable and accurate analyses of the cell conditions they were preclinical tested for, such as apoptosis. The detection of apoptotic cells by annexin V (AV) coupled to fluorophore
Externí odkaz:
https://doaj.org/article/c05b4978132b4524b68c1177dd13fb04
Autor:
Diana Klose, Mira Woitok, Judith Niesen, Roger R Beerli, Ulf Grawunder, Rainer Fischer, Stefan Barth, Rolf Fendel, Thomas Nachreiner
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180305 (2017)
The antigen-specific targeting of autoreactive B cells via their unique B cell receptors (BCRs) is a novel and promising alternative to the systemic suppression of humoral immunity. We generated and characterized cytolytic fusion proteins based on an
Externí odkaz:
https://doaj.org/article/3d8df7af4837489b88b6d6e8d638ee06
Autor:
Rolf Fendel, Olusiji A. Akinrinmade, Elena Grieger, Mira Woitok, Stefan Barth, Susanne Bethke, Anh Tuan Pham, Judith Niesen, Christoph Stein, Rainer Fischer
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243286 (2020)
PLOS ONE 15(12), e0243286 (2020). doi:10.1371/journal.pone.0243286
PLoS ONE
PLOS ONE 15(12), e0243286 (2020). doi:10.1371/journal.pone.0243286
PLoS ONE
PLOS ONE 15(12), e0243286 (2020). doi:10.1371/journal.pone.0243286
Published by PLOS, San Francisco, California, US
Published by PLOS, San Francisco, California, US
Autor:
Mira Woitok, Christoph Stein, Rainer Fischer, Stefan Barth, Rolf Fendel, Judith Niesen, Grit Hehmann-Titt
Publikováno v:
Cancer Letters. 374:229-240
Human cytolytic fusion proteins (hCFPs) offer a promising immunotherapeutic approach for the treatment of solid tumors, avoiding the immunogenicity and undesirable side-effects caused by immunotoxins derived from plants or bacteria. The well-characte
Autor:
Verena von Felbert, Stefan Barth, Mira Woitok, K. Bräutigam, Ivo Meinhold-Heerlein, Ahmad Fawzi Hussain, Dirk Bauerschlag, Nicolai Maass
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 142:1003-1011
Purpose The term ""theranostics"" represents a new paradigm in medicine especially for cancer treatment. This term was coined by Funkhouser in 2002 and defines a reagent that combines therapeutic and diagnostic properties. It is widely believed that
Autor:
Gisela Maria Hanz, Felix Zeppernick, Ivo Meinhold-Heerlein, Elmar Stickeler, Rainer Fischer, Ahmad Fawzi Hussain, Gerrit Gresch, Katharina Kolberg, Andreas Bleilevens, Claudia Kessler, Dirk Bauerschlag, Anka Maria Haugg, Elmar Weinhold, Karinna Chouman, Nicolai Maass, Radoslav Mladenov, Mira Woitok
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 17
Background Targeted imaging and therapy (theranostics) is a promising approach for the simultaneous improvement of cancer diagnosis, prognosis and management. Therapeutic and imaging reagents are coupled to tumor-targeting molecules such as antibodie
Autor:
Rolf Fendel, Mira Woitok, Gerrit Gresch, Stefan Barth, Rainer Fischer, Christoph Stein, Elena Grieger, Judith Niesen
Publikováno v:
Journal of cancer research and clinical oncology. 143(11)
Treatment of cancer using standard chemotherapy still offers a poor prognosis combined with severe side effects. Novel antibody-based therapies have been shown to overcome low efficiency and lack of selectivity by targeting cancer-associated antigens
Autor:
Mira Woitok, Rainer Fischer, Judith Niesen, Ulf Grawunder, Thomas Nachreiner, Roger R. Beerli, Stefan Barth, Rolf Fendel, Diana Klose
Publikováno v:
PLOS ONE 12(7), e0180305 (2017). doi:10.1371/journal.pone.0180305
PLoS ONE, Vol 12, Iss 7, p e0180305 (2017)
PLoS ONE
PLoS ONE, Vol 12, Iss 7, p e0180305 (2017)
PLoS ONE
PLoS one 12(7), e0180305 (2017). doi:10.1371/journal.pone.0180305
Published by PLoS, Lawrence, Kan.
Published by PLoS, Lawrence, Kan.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26757820ba689e1362a82b014374df47
Autor:
Rainer Fischer, Mira Woitok, Stefan Barth, Muhammad Abbas, Magdalena Bialon, Christoph Stein, Judith Niesen, Rolf Fendel, Diana Klose, Katharina Kolberg, Christiane Püttmann, Wolfgang Richter
Publikováno v:
Cancer letters. 381(2)
Antibody-drug conjugates (ADCs) combine the potency of cytotoxic drugs with the specificity of monoclonal antibodies (mAbs). Most ADCs are currently generated by the nonspecific conjugation of drug-linker reagents to certain amino acid residues in mA
Autor:
Christoph Stein, Edgar Jost, Rolf Fendel, Manal Amoury, Mira Woitok, Diana Klose, Christian Cremer, Lea Schenke, Elena Grieger, Gerrit Gresch, Tim H. Brümmendorf, Rainer Fischer, Theo Thepen, Dmitrij Hristodorov, Radoslav Mladenov, Stefan Barth
Publikováno v:
Oncotarget
OncoTarget 7(41), 67166-67174 (2016). doi:10.18632/oncotarget.11568
OncoTarget 7(41), 67166-67174 (2016). doi:10.18632/oncotarget.11568
OncoTarget 7(41), 67166-67174 (2016). doi:10.18632/oncotarget.11568
Published by Impact Journals LLC, [S.l.]
Published by Impact Journals LLC, [S.l.]